A Joint Approach to Psoriatic Disease Management: Bimzlex for your Patients with PsO and PsA
- This event has passed.
A Joint Approach to Psoriatic Disease Management: Bimzlex for your Patients with PsO and PsA
Speakers: Saakshi Khattri, MD, MBBS, FAAD, FACR Director, Dermatology/Rheumatology Service Icahn School of Medicine, Mount Sinai New York, New York and Gordan K. Lam MD Board-Certified Rheumatologist Atrium Health Carolinas Medical Center
Moderator: Leon Kircik, MD, FAAD Medical Director, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY Indiana University Medical Center, Indianapolis, IN Medical Director Physicians Skin Care, PLLC, Louisville, KY DermResearch, PLLC, Louisville, KY Skin Sciences, PLLC, Louisville, KY
Please join us for our next IDF Educational Series Webinar: A Joint Approach to Psoriatic Disease Management: Bimzlex for your Patients with PsO and PsA. Bimzelx is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy, active psoriatic arthritis, active non radiographic axial spondyloarthritis with objective signs of inflammation, active ankylosing spondylitis, and moderate to severe hidradenitis suppurativa.